Anzeige
Meldung des Tages: Insider kaufen kräftig zu – 421.670 CAD an Käufen, während Silber $88 erreicht

Coherus Oncology News

Aktie
WKN:  A12ETZ ISIN:  US19249H1032 US-Symbol:  CHRS Branche:  Biotechnologie Land:  USA
1,635 $
-0,06 $
-3,54%
1,4321 € 13.03.26
Depot/Watchlist
Marktkapitalisierung *
130,98 Mio. €
Streubesitz
44,17%
KGV
-1,01
Index-Zuordnung
-

Coherus Oncology News

27.01.26 - PR Newswire
Registration-Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks
Registration-​Ready: How 2026's Clinical Leaders Are Beating Cancer Benchmarks PR Newswire
16.01.26 - PR Newswire
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape PR Newswire
08.02.25 - Börse-Global
Coherus BioSciences Aktie: Frohe Kunde für Anleger!
Die Coherus BioSciences, ein auf Biosimilars und Immunonkologie spezialisiertes Unternehmen, verzeichnete am gestrigen Handelstag einen leichten Kursanstieg von 2,65 ...
02.02.25 - Börse-Global
Coherus BioSciences Aktie: Steigende Unsicherheiten?
Die Coherus BioSciences Aktie verzeichnete am 1. Februar 2025 einen signifikanten Einbruch von 11,11 Prozent auf 1,20 Euro. Der US-​amerikanische Biopharmakonzern, der sich ...
08.12.24 - Börse-Global
Coherus BioSciences Aktie: Neue Möglichkeiten im Blick!
Die Aktie des Biosimilar-​Spezialisten Coherus BioSciences zeigt zum Jahresende eine bemerkenswerte Entwicklung an den Börsen. Mit einem aktuellen Kurs von 1,59 EUR konnte ...
19.01.24 - PR Newswire
Thinking about buying stock in YanGuFang International, Broadcom, Applied Digital, Intelligent Bio Solutions, or Coherus Biosciences?
Thinking about buying stock in YanGuFang International, Broadcom, Applied Digital, Intelligent Bio Solutions, or Coherus Biosciences? PR Newswire
04.01.24 - PR Newswire
INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)
INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-​tpzi) PR Newswire
28.12.23 - PR Newswire
Thinking about buying stock in Riot Platforms, Coherus Biosciences, AC Immune, Wisekey International Holding, or NXU Inc.?
Thinking about buying stock in Riot Platforms, Coherus Biosciences, AC Immune, Wisekey International Holding, or NXU Inc.? PR Newswire
27.12.23 - PR Newswire
Thinking about buying stock in Cingulate, Gracell Biotechnologies, Eli Lilly, ESSA Pharma, or Coherus Biosciences?
Thinking about buying stock in Cingulate, Gracell Biotechnologies, Eli Lilly, ESSA Pharma, or Coherus Biosciences? PR Newswire
17.11.23 - PR Newswire
Thinking about buying stock in Coinbase Global, Celsius Holdings, Cadence Design Systems, Coherus Biosciences, or Fortress Biotech?
Thinking about buying stock in Coinbase Global, Celsius Holdings, Cadence Design Systems, Coherus Biosciences, or Fortress Biotech? PR Newswire
07.11.23 - PR Newswire
Thinking about buying stock in Applied Therapeutics, Coherus Biosciences, Tempest Therapeutics, Bluegreen Vacations Holding, or Adams Resources & Energy?
Thinking about buying stock in Applied Therapeutics, Coherus Biosciences, Tempest Therapeutics, Bluegreen Vacations Holding, or Adams Resources & Energy? PR Newswire
01.11.23 - PR Newswire
Thinking about buying stock in AERWINS Technologies, Arista Networks, Lucid Group, C3.ai, or Coherus Biosciences?
Thinking about buying stock in AERWINS Technologies, Arista Networks, Lucid Group, C3.ai, or Coherus Biosciences? PR Newswire
30.10.23 - PR Newswire
Thinking about buying stock in Coherus Biosciences, Vyne Therapeutics, Intuitive Machines, SoFi Technologies, or Cybin?
Thinking about buying stock in Coherus Biosciences, Vyne Therapeutics, Intuitive Machines, SoFi Technologies, or Cybin? PR Newswire
01.09.23 - PR Newswire
Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600
Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 PR Newswire
23.12.22 - PR Newswire
Thinking about buying stock in ReShape Lifesciences, Exicure, Blue Apron, Coherus Biosciences, or Icecure Medical?
Thinking about buying stock in ReShape Lifesciences, Exicure, Blue Apron, Coherus Biosciences, or Icecure Medical? PR Newswire
02.02.21 - GlobeNewswire
Coherus BioSciences to Receive $50 million Strategic Investment from Immuno-Oncology Partner Junshi Biosciences
REDWOOD CITY, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- A day after announcing their new immuno-​oncology collaboration, Coherus BioSciences, Inc. (Nasdaq: CHRS) ...
11.09.17 - Aktienwelt360
AbbVie erzielt 2 wichtige Fortschritte – einer davon bedroht Regeneron
Die Aktie von AbbVie (WKN:A1J84E) stieg stark, nachdem das Unternehmen einen Sieg im Patentenstreit gegen Coherus Biosciences (WKN:A12ETZ) verbuchen konnte. Zusätzlich ...
02.04.15 - EQS
amp biosimilars AG: Zweiter deutscher Biosimilars-'pure play' an der Börse
DGAP-News: amp biosimilars AG / Schlagwort(e): Börsen­gang amp biosimilars AG: Zweiter deutscher Biosimilars-'pure play' an der Börse 02.04.2015 / 06:30 ---------------------------------...

Newssuche

Videos

newspaper
13.03.26 -3,08%
Technical Trading: Kurzfristig Gold Long
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »